⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIMS News
Hims & Hers Health, Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
prnewswire.com
HIMS
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
HIMS
Pomerantz LLP Notifies Shareholders of Class Action Lawsuit Against Hims & Hers Health, Inc. – HIMS
accessnewswire.com
HIMS
INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline - HIMS
prnewswire.com
HIMS
META
SNAP
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026
accessnewswire.com
HIMS
HIMS 12-DAY DEADLINE ALERT: Hims & Hers Health Faces Securities Fraud Class Action, Investors with Losses Encouraged to Contact Hagens Berman
prnewswire.com
HIMS
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to an Upcoming Deadline of November 2, 2026 in the Securities Class Action
globenewswire.com
HIMS
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
businesswire.com
HIMS
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
XOM
JPM
AMD
PYPL
MRNA
MSTR
SNOW
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
INTC
SPCX
MU
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
globenewswire.com
HIMS